{"variables":{"96653":{"years":[2000,2000,2030,2030,2050,2050,2070,2070,2100,2100],"entities":[37483,13,13,37483,13,37483,13,37483,13,37483],"values":[17,36,233,121,705,348,1980,1017,6530,3468],"id":96653,"name":"Excess skin cancer cases per million (no restrictions)","unit":"excess skin cancer cases per million","description":"","createdAt":"2018-04-06T15:26:02.000Z","updatedAt":"2018-04-06T15:26:02.000Z","code":null,"coverage":"","timespan":"","datasetId":2733,"sourceId":15466,"shortUnit":null,"display":{},"columnOrder":0,"originalMetadata":null,"datasetName":"Ozone depletion impacts on skin cancer incidence - Slaper et al.","s_id":15466,"s_name":"Ozone depletion impacts on skin cancer incidence - Slaper et al.","source":{"id":15466,"name":"Ozone depletion impacts on skin cancer incidence - Slaper et al.","dataPublishedBy":"Slaper, H. et al. Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature 384(6606): 256–258 (1996).","dataPublisherSource":"","link":"https://www.nature.com/articles/384256a0.pdf","retrievedData":"","additionalInfo":"The authors modelled the number of excess skin cancer cases they would expect among fair-skinned populations in the United States and Northwest Europe as a result of stratospheric ozone depletion.\n\nThis was modelled for a scenario of no restrictions on ozone-depleting substances, where the authors assumed a 3% annual increase in emissions of chloroflourocarbons (CFCs), halons and methyl chloroforms. \n\nThe Montreal Protocol scenario assumed a decline of five important ozone-depleting substances by 50% by the end of 1999 as agreed in the protocol in 1987.\n\nThe Copenhagen Amendment assumed the production of 21 ozone-depleting substances reduced to zero by the end of 1995."}},"96654":{"years":[2000,2000,2030,2030,2050,2050,2070,2070,2100,2100],"entities":[37483,13,37483,13,13,37483,13,37483,13,37483],"values":[17,36,103,192,420,231,758,414,1958,1051],"id":96654,"name":"Excess skin cancer cases per million (Montreal Protocol)","unit":"excess skin cancer cases per million","description":"","createdAt":"2018-04-06T15:26:02.000Z","updatedAt":"2018-04-06T15:26:02.000Z","code":null,"coverage":"","timespan":"","datasetId":2733,"sourceId":15466,"shortUnit":null,"display":{},"columnOrder":0,"originalMetadata":null,"datasetName":"Ozone depletion impacts on skin cancer incidence - Slaper et al.","s_id":15466,"s_name":"Ozone depletion impacts on skin cancer incidence - Slaper et al.","source":{"id":15466,"name":"Ozone depletion impacts on skin cancer incidence - Slaper et al.","dataPublishedBy":"Slaper, H. et al. Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature 384(6606): 256–258 (1996).","dataPublisherSource":"","link":"https://www.nature.com/articles/384256a0.pdf","retrievedData":"","additionalInfo":"The authors modelled the number of excess skin cancer cases they would expect among fair-skinned populations in the United States and Northwest Europe as a result of stratospheric ozone depletion.\n\nThis was modelled for a scenario of no restrictions on ozone-depleting substances, where the authors assumed a 3% annual increase in emissions of chloroflourocarbons (CFCs), halons and methyl chloroforms. \n\nThe Montreal Protocol scenario assumed a decline of five important ozone-depleting substances by 50% by the end of 1999 as agreed in the protocol in 1987.\n\nThe Copenhagen Amendment assumed the production of 21 ozone-depleting substances reduced to zero by the end of 1995."}},"96655":{"years":[2000,2000,2030,2030,2050,2050,2070,2070,2100,2100],"entities":[13,37483,13,37483,13,37483,13,37483,13,37483],"values":[31,14,102,58,148,89,122,77,35,23],"id":96655,"name":"Excess skin cancer cases per million (Copenhagen Amendments)","unit":"excess skin cancer cases per million","description":"","createdAt":"2018-04-06T15:26:02.000Z","updatedAt":"2018-04-06T15:26:02.000Z","code":null,"coverage":"","timespan":"","datasetId":2733,"sourceId":15466,"shortUnit":null,"display":{},"columnOrder":0,"originalMetadata":null,"datasetName":"Ozone depletion impacts on skin cancer incidence - Slaper et al.","s_id":15466,"s_name":"Ozone depletion impacts on skin cancer incidence - Slaper et al.","source":{"id":15466,"name":"Ozone depletion impacts on skin cancer incidence - Slaper et al.","dataPublishedBy":"Slaper, H. et al. Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature 384(6606): 256–258 (1996).","dataPublisherSource":"","link":"https://www.nature.com/articles/384256a0.pdf","retrievedData":"","additionalInfo":"The authors modelled the number of excess skin cancer cases they would expect among fair-skinned populations in the United States and Northwest Europe as a result of stratospheric ozone depletion.\n\nThis was modelled for a scenario of no restrictions on ozone-depleting substances, where the authors assumed a 3% annual increase in emissions of chloroflourocarbons (CFCs), halons and methyl chloroforms. \n\nThe Montreal Protocol scenario assumed a decline of five important ozone-depleting substances by 50% by the end of 1999 as agreed in the protocol in 1987.\n\nThe Copenhagen Amendment assumed the production of 21 ozone-depleting substances reduced to zero by the end of 1995."}}},"entityKey":{"13":{"name":"United States","code":"USA"},"37483":{"name":"Northwest Europe","code":null}}}